Engaging openly with that process including reporting unexpected changes in weight or any new symptoms contributes to the broader evidence base and ensures your own care remains appropriately tailored
These were generally consistent with the known side-effect profile of GLP-1 receptor agonists and were most frequently observed during the dose-escalation phase
Enomoto and colleagues further demonstrated that developmental increases in I NaP and I NaR currents are critical for supporting high-frequency firing, providing a basis for age-dependent changes in MTN excitability (Enomoto et al., 2018
Danuglipron, an oral glucagon-like peptide-1 (GLP-1) receptor agonist, will undergo dose optimization studies in the second half of 2024 as Pfizer seeks to evaluate multiple doses of the formulation which they hope will inform the registration-enabling studies
This keeps them super consistent, but also makes them lack in some flare
Treatment of Allergic Rhinitis in Clinical Practice